Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 153.27
-0.013 %
$ 15.5 B
Market Cap
40.87
P/E
NBIX - TOTAL EQUITY
Total Equity NBIX - Neurocrine Biosciences, Inc.
2.23 B
LAST VALUE
27.45%
2 YEAR CAGR
35.94%
5 YEAR CAGR
33.91%
10 YEAR CAGR